• Facilities
    • Cork, Ireland
    • Cramlington, UK
    • Deeside, UK
    • Newcastle Biosphere, UK
    • North Carolina, US
    • Wisconsin, US
  • Sustainability
    • Environmental sustainability
  • Molecule Lifecycle
    • Discovery
    • Preclinical
    • Phase One
    • Phase Two
    • Phase Three
    • Launch
  • About Us
    • Our Heritage
    • Vision and Values
    • HSE
    • Quality and Regulatory
    • Technology and Innovation Programme
    • PDMO
    • Executive Team
    • Community
  • Careers Hub
    • Our Vacancies
    • Life at Sterling
    • STEM
    • Early Career Paths at Sterling
    • Professional Career Paths at Sterling
    • Meet our People
    • Our Locations
  • News and Events
    • News
    • Events
  • Contact
Sterling Pharma Solutions Logo
Sterling Pharma Solutions Logo
✕
  • Dedicated Scientists
    • Full Time Equivalent (FTE)
    • Extended Benchâ„¢
  • Chemistry Services
    • Drug Discovery
    • Early Scale Up
    • Analytical Services
    • Radiolabelling
  • Small Molecules
    • Small Molecule Services
      • API Development
      • API Manufacturing
      • Commercial API Lifecycle Management
      • CMC Services
      • Solid State Chemistry
      • Milling/Micronisation
    • Small Molecule Technologies
      • Hazard Evaluation
      • Chiral Chemistry
      • Hazardous Chemistry
      • Diazomethane
      • Continuous | Flow
      • Biocatalysis
      • High Potency APIs
      • Controlled Substances
  • Peptides
  • ADCs
    • ADC Development
    • ADC Analytical Services
    • Mass Spectrometry
    • ADC Clinical Manufacturing
    • Linker Payloads
  • Knowledge Hub
  • Home
  • Dedicated Scientists
    • Full Time Equivalent (FTE)
    • Extended Benchâ„¢
  • Chemistry Services
    • Drug Discovery
    • Early Scale Up
    • Analytical Services
    • Radiolabelling
  • Small Molecules
    • Small Molecule Services
      • API Development
      • API Manufacturing
      • CMC Services
      • Solid State Chemistry
      • Milling/Micronisation
    • Small Molecule Technologies
      • Hazard Evaluation
      • Chiral Chemistry
      • Hazardous Chemistry
      • Diazomethane
      • Continuous | Flow
      • High Potency APIs
      • Controlled Substances
  • Peptides
  • ADCs
    • ADC Development
    • ADC Analytical Services
    • Mass Spectrometry
    • ADC Clinical Manufacturing
    • Linker Payloads
  • Molecule Lifecycle
  • Knowledge Hub
  • About Us
    • Our Heritage
    • HSE
    • Quality and Regulatory
    • Technology and Innovation Programme
    • PDMO
    • Executive Team
    • Community
  • Facilities
  • Sustainability
  • Careers Hub
    • Our Vacancies
    • Life at Sterling
    • STEM
    • Early Career Paths at Sterling
    • Professional Career Paths at Sterling
    • Vision and Values
    • Meet our People
    • Our Locations
  • News and Events
  • Contact
Home - Knowledge Hub - Facilities - Sterling’s North Carolina Facility Virtual Tour

Sterling’s North Carolina Facility Virtual Tour

360 Virtual Tour1 min read 20th Jul 2021
Share via email Share via LinkedIn

Want to find out more about our North Carolina, US facility? Click here.

Related articles

Map showing Sterling's global network of facilities in UK, USA and EU
2 min read
Facilities

Six facilities across the US, UK and EU.

Read more
Facilities
Video2 min read
Facility overview video: North Carolina, US Read more
Share via email Share via LinkedIn

Popular articles

7 min read
Why pharmaceutical manufacturing strategy should look ahead to patent expiry Read more
Scientist in Sterling labs using equipment used during radiochemistry projects
6 min read
Why radiolabelling should be part of your early drug development strategy Read more
Sterling Pharma Solutions' new analytical lab for ADCs and bioconjugation following recent investment at its Deeside, Wales facility News
News2 min read
Sterling Expands ADC Manufacturing Capacity and Capabilities Read more
Scientist in Sterling's analytical laboratories API Manufacturing
Blog6 min read
Unlock the UK-US tariff advantage: What it means for you Read more
Poster Presentation3 min read
Lost in translation: Platform analysis of an antibody oligonucleotide conjugate Read more
Scientist in Sterling labs using equipment used during radiochemistry projects
Blog6 min read
Integrating generative AI into process chemistry workflows Read more

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

This field is for validation purposes and should be left unchanged.
Name(Required)
This field is hidden when viewing the form
Please click here for our privacy policy
Sterling Pharma Solutions Footer LogoService. Passion. Science.
linkedin iconfacebook iconyoutube icon
Enquire now
  • Privacy Policy
  • Cookie Policy
  • Manage Cookies
  • Website Terms and Conditions
  • Gender Pay Gap
  • Modern Slavery Policy

PDMO® is registered in the U.S. Patent and Trademark Office.

PDMO® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.
VAT number: GB320549229